Need Help?
Contact Us

Caution: Eluvia is an investigational device. Limited by US law to investigational use only. Not available for sale.

"We have clear data that the drug-eluting stent technology outperforms a bare metal stent."

Professor Erwin Blessing, MD
SRH Hospital | Karlsbad, Germany

MAJESTIC 1- and 2-Year Primary Patency1


Clinically Studied Therapies


Find out how Boston Scientific’s drug-eluting technologies continue to deliver unprecedented clinical outcomes in patients with peripheral artery disease (PAD).

Eluvia Drug-Eluting Vascular Stent System

The Eluvia Drug-Eluting Stent showed unprecedented clinical outcomes—with a 83.5% primary patency at 2 years, the highest reported in comparable SFA clinical trials.

Drug Tissue Concentrations Over Time 2


Investing in Drug-Eluting Technology


Find out how we’re leveraging nearly 20 years of design and development experience to advance the science of drug-eluting technologies and improve patient lives.

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.

Explore DE Resources

Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.

Top